Literature DB >> 26430501

The Effect of Pulmonary Valve Replacement (PVR) Surgery on Hemodynamics of Patients Who Underwent Repair of Tetralogy of Fallot (TOF).

Hamid Bigdelian1, Davoud Mardani2, Mohsen Sedighi2.   

Abstract

INTRODUCTION: Pulmonary insufficiency (PI) frequently develops in patients who underwent repair of tetralogy of fallot (TOF). The aim of present study was to assess the effect of pulmonary valve replacement (PVR) on hemodynamics of patients who underwent repair of TOF.
METHODS: This retrospective cohort carried out between July 2010 and October 2012 among consecutive PVRs of 19 patients who underwent TOF surgery. The PVRs was performed using bioprosthetic (n=17) and mechanical (n=2) valves. Our data was collected during follow up visits within 6 to 12 month after PVR.
RESULTS: Our results show that PVR significantly decreased right ventricular end-diastolic volume (180.89±13.78 vs. 107.21±12.02 ml/m(2), P < .01), right ventricular end-systolic volume (105.42±15.98 vs. 58.15±11.67 ml/m(2), P < .01), RV mass (47.78±6.20 vs. 30.68±8.95 g/m(2), P < .01), and PI (48.21±1.43% vs. 12.68±5.60%, P < .01). Moreover, left ventricular end-diastolic volume significantly increased (78.05±17.21 vs. 90.78±14.82 ml/m(2), P < .01) after PVR. The other hemodynamics indexes did not change, significantly.
CONCLUSION: Despite the controversies about efficacy of PVR after repair of TOF, the remarkable improvement of hemodynamic is a supportive rationale for performing PVR surgery in TOF patients.

Entities:  

Keywords:  Cardiac Magnetic Resonance; Congenital Surgery; Prosthetic Valve; Pulmonary Regurgitation

Year:  2015        PMID: 26430501      PMCID: PMC4586599          DOI: 10.15171/jcvtr.2015.26

Source DB:  PubMed          Journal:  J Cardiovasc Thorac Res        ISSN: 2008-5117


Introduction

Tetralogy of fallot (TOF) is one of the most common congenital heart disease.[1] Pulmonary insufficiency (PI) is a common adverse event after TOF repair. Chronic cardiac overload which caused by PI, can result in cardiac (RV) wall enlargement, RV failure, heart failure, arrhythmias and unfortunately sudden cardiac death. Pulmonary valve replacement (PVR) may be indicated for the purpose of preventing permanent alterations of cardiac walls and hemodynamics.[2,3] Although PVR performed by numerous surgeons for many years, the effect of PVR still remains controversial. Despite the evidences of recovered cardiac function and hemodynamics post-PVR, the beneficial effect of PVR on prevention of alterations of ventricular mass, volumes, and hemodynamics remains unclear and indications for PVR are restricted to limited conditions such as RVOT dysfunction.[1] In our center, symptomatic patients with the symptoms like as exercise intolerance, clinical arrhythmia, and right ventricular failure that unequivocally caused by severe PI and the asymptomatic patients with RVEDV greater than 170 ml/m2 in cardiac MRI (CMRI) were routinely undergoing PVR. This study was carried out with aim of assessment of the effect of PVR surgery on hemodynamic indexes of patients who undergone total repair of TOF.

Material and Methods

Patients and Study Design

After approval of institutional committee of ethic, 19 consecutive TOF patients who underwent PVR between July 2010 and October 2012 were included in our cohort. All patients was underwent TOF correction prior to PVR. Our study population included a number of 17 PVRs with bioprosthetic valves (using St. Jude Medical EpicTM) and 2 PVRs with mechanical valves (using St. Jude mechanical valves). The PVRs performed on cardio-pulmonary pump (CPB) or on beating heart (in the absent of right to left shunt). The size of valve was selected based on surgeon’s preference (always one size larger than native valve annulus). Both of mechanical or bioprosthetic valves were inserted into orthotopic position. All data of these PVRs was collected from review of medical records of surgeon and hospital database. Moreover, results of CMRI studies were collected during follow up clinical visits at the time between 6th and 12th month after PVR.

Statistical Methods

Data were analyzed using SPSS software (version 16, SPSS Inc, Chicago, IL, USA). Categorical data described as frequency (percent) and continuous data presented as mean ± standard deviation. The student t test was used to find any significant difference between hemodynamic parameters before and after surgery. The P value less than 0.05 was considered as significant level for all tests.

Result

The perioperative and late outcomes of patients after PVR surgery was summarized in Table 1. As the Table 1 shows, TOF with pulmonary stenosis (PS) is the most common (63.2%)diagnosis of our patients, and the rest of them (26.3%) had TOF with pulmonary atresia (PA), and TOF with PA and PS (10.5%). The sternum of five patients (26.3%) remains open as a strategy, because of cardiac failure, edema, and prolonged CPB. Total ICU stay of patients was 2.96±036 and their hospital stay was 15.00±1.36 day. Additionally, the only one death after PVR (with mechanical valve), was related to right ventricular failure which caused by thrombosis of prosthetic valve.
Table 1

Characteristics of Patients

Variable Mean±SD or No. (%) a
Prioperative
Age, year12.00±5.31
Gender
Male6 (31.6%)
Female13 (68.4%)
Diagnosis
TOF+PA5 (26.3%)
TOF+PS12 (63.2%)
TOF+PA+PS2 (10.5%)
Open sternum strategy5 (26.3%)
Renal failure0 (0%)
Cerebral accident1 (5.3%)
ICU stay, day2.96±036
Hospital stay, day15.00±1.36
Late outcomes b
Valve dysfunction1 (5.3%)
RV failure1 (5.3%)
Ventricular tachycardia 0 (0%)
Infection 0 (0%)
Thromboembolism1 (5.3%)
Mortality1 (5.3%)

Abbreviations‏: BPV, bioprosthesis valve; MCV, mechanical valve; TOF, tetralogy of fallot; PA, pulmonary atresia; PS, pulmonary stenosis; ICU, intensive care unit; RV, right ventricular.

a Continues data are presented as Mean ± Standard Deviation and Categorical data are presented as Frequency (Percentage)

b All of late outcomes are related to first year follow-up visits after PVR surgery.

Abbreviations‏: BPV, bioprosthesis valve; MCV, mechanical valve; TOF, tetralogy of fallot; PA, pulmonary atresia; PS, pulmonary stenosis; ICU, intensive care unit; RV, right ventricular. a Continues data are presented as Mean ± Standard Deviation and Categorical data are presented as Frequency (Percentage) b All of late outcomes are related to first year follow-up visits after PVR surgery. As the Table 2 shows, right ventricular volumes significantly decreased after PVR surgery. The Right ventricular end-diastolic volume (RVEDV) shows significant decrease in follow-up measurements (180.89±13.78 vs. 107.21±12.02, P <.01). Also, the Right ventricular end-systolic volume (RVESV) significantly decreased after surgery (105.42±15.98 vs. 58.15±11.67, P<.01). Correspondingly, the CMRI results show the substantially shrinkage of right ventricular (RV) mass after PVR (47.78±6.20 vs. 30.68±8.95, P<.01). Moreover, right ventricular ejection fraction (RVEF) improved after valve replacement, but this improvement was not statistically significant (41.45±5.45 vs. 43.30±9.67, P=.11).
Table 2

Comparison of CMRI Characteristics of Patients Before and After PVR

Variable a Subjects (n=19) P Value
Before PVR After PVR
RVEDV (ml/m2) 180.89±13.78107.21±12.02<0.01
RVESV (ml/m2) 105.42±15.9858.15±11.67<0.01
RV EF (%)41.45±5.4543.30±9.670.11
RV mass (g/m2) 47.78±6.2030.68±8.95<0.01
LVEDV (ml/m2) 78.05±17.2190.78±14.82<0.01
LVESV (ml/m2) 37.04±7.1938.82±6.300.67
LV EF (%)47.07±18.3155.77±7.860.09
PI (%)48.21±1.4312.68±5.60<0.01

Abbreviations: CMRI, cardiac magnetic resonance imaging; PVR, pulmonary valve replacement; RVEDV, right ventricular end-diastolic volume; RVESV, right ventricular end-systolic volume; RVEF, right ventricular ejection fraction; RV mass= right ventricular mass; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejection fraction; PI, pulmonary insufficiency.

a Continues data are presented as Mean ± Standard Deviation ad analyzed using t test.

Abbreviations: CMRI, cardiac magnetic resonance imaging; PVR, pulmonary valve replacement; RVEDV, right ventricular end-diastolic volume; RVESV, right ventricular end-systolic volume; RVEF, right ventricular ejection fraction; RV mass= right ventricular mass; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejection fraction; PI, pulmonary insufficiency. a Continues data are presented as Mean ± Standard Deviation ad analyzed using t test. As depicted in Figure 1, the alterations of left ventricular volumes show advantageous effect of PVR on left ventricle. Our result shown that PVR increased quantities of Left ventricular end-diastolic volume (LVEDV) (78.05±17.21 vs. 90.78±14.82, P<.01), left ventricular end-systolic volume LVESV) (37.04±7.19 vs. 38.82±6.30, P=.09), and left ventricular ejection fraction (LVEF) (47.07±18.31 vs. 55.77±7.86, P=.09). As our result shown, although the improvement of LV hemodynamics, only increase of LVEDV was statistically significant. Furthermore, PVR surgery resulted in significant decrease in incidence of PI (48.21±1.43% vs. 12.68±5.60%, P<.01).
Figure 1
The CMRI image of an 18 year old male patient before and after PVR.

Discussion

Chronic forces against the cardiomyocytes is a trigger for muscular hypertrophy and cardiac wall thickening.[4] Therefore, correction of PI can result in shrinkage of RV mass by decrease of RV load. In accordance with previous studies, our results indicate a significant decrease in RVEDV and RVESV after PVR.[5,6] These results confirm the hypothesis that RV mass can significantly decreased by PVR. In other words, PVR can gradually result in RV remodeling by removal of overloaded pressure on RV myocytes. Surprisingly, despite the shrinkage of expanded RV wall and improvement of RV hemodynamic, RVEF failed to show a significant improvement. Bove and colleagues[5] founded a significant shrinkage of dilated RV (RVD) and improvement in exercise tolerance after PVR surgery but they reported only a trivial increase in RVEF. In contrary, the report of Vliegen et al[7] indicated that RVD and RVEF can improve after the surgery. Evidences suggest that the probability of RV regression considerably decreases in presence of preoperative RVEDV>160-170 ml/m2 or RVESV>80-90 ml/m2.[6] Therefore, we concluded that the efficacy of PVR is limited to the RV volumes lower than this limit. Despite the fact that PVR can effectively reduce RV size, its effects on RV function may be limited because of the increased scar and fibrotic tissue in the RV wall. Silberman et al[4] studied the behavior of ventricles after implantation of stentless valves, by assessment of gradients and effective orifice area (EOA) index in patients who underwent aortic valve surgery. They concluded that rapid improvement of ventricular function is highly depended on valve performance rather than ventricular regression. High gradient across the functioning prosthetic valve can suspend recovery of RV function. Therefore, another probability is that improvement of RV function is a long-term process that may need more time to develop. The current evidences suggest that early restoration of pulmonary valve function can fully normalize the RV hemodynamic, but the exact time of PVR remains unknown.[8,9] LV dysfunction frequently is a common finding in symptomatic patients with TOF and implies that the presence of the severe RV disease may be a cause for LV dysfunction. Therefore, management of congenital RV anomalies may improve the LV function and clinical symptoms.[10] Likewise, our results show that the PVR surgery could effect on LV volumes as well as RV volumes. It was postulated that interaction between LV and RV chambers is mainly related to mutual myocardial fibers between LV and RV. Additionally, incline of the nestled interventricular septum into the LV cavity can decrease left ventricular refilling during diastole phase. Hence, LV hypertrophy (LVH) could result as an important compensatory mechanism for unfilled LV to increase cardiac output.[6,11] Our study supports this experience and show that parameters of LVEDV (significantly), LVESV, and LVEF (non-significantly) increased after PVR. This study has several limitations. There is a noticeable difficulty in homogeneous surgical recruitment of patients because patients may be referred for surgery at different stages of PI or RVOT dysfunction. Moreover, small size of our study population counts as another major limitation of this study.

Conclusion

In conclusion, our study indicates that PVR surgery can successfully normalize the impaired hemodynamic of patients who previously underwent repair of TOF. Although there is a controversy about effect of PVR in TOF patients among experts, the remarkable improvement of hemodynamic after PVR is a supportive rationale of performance of this surgery before RV hemodynamic reaches to RVEDV>160-170 ml/m2 or RVESV>80-90 ml/m2. Unexpectedly, despite the fact that PVR significantly improves RV size and volume, RV function remained impaired after PVR. We concluded that early PVR surgery can initiate RV remodeling and improvement of RV function. Hence, in order to prevention of development irreversible alterations in cardiac walls, the PVR surgery should be consider in TOF patients with the upper threshold levels as soon as possible.
  10 in total

1.  Exercise hemodynamics of aortic prostheses: comparison between stentless bioprostheses and mechanical valves.

Authors:  S Silberman; J Shaheen; O Merin; D Fink; N Shapira; N Liviatan-Strauss; D Bitran
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

2.  Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging.

Authors:  Tal Geva; Bryan M Sandweiss; Kimberlee Gauvreau; James E Lock; Andrew J Powell
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094

3.  Right ventricular function after pulmonary valve replacement in patients with tetralogy of Fallot.

Authors:  Alexander van Straten; Hubert W Vliegen; Mark G Hazekamp; Jeroen J Bax; Paul H Schoof; Jaap Ottenkamp; Ernst E van der Wall; Albert de Roos
Journal:  Radiology       Date:  2004-12       Impact factor: 11.105

Review 4.  Pulmonary regurgitation in congenital heart disease.

Authors:  Rajiv R Chaturvedi; Andrew N Redington
Journal:  Heart       Date:  2007-07       Impact factor: 5.994

5.  Pulmonary valve replacement in adults late after repair of tetralogy of fallot: are we operating too late?

Authors:  J Therrien; S C Siu; P R McLaughlin; P P Liu; W G Williams; G D Webb
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

6.  Late pulmonary valve replacement after repair of tetralogy of Fallot.

Authors:  B Discigil; J A Dearani; F J Puga; H V Schaff; D J Hagler; C A Warnes; G K Danielson
Journal:  J Thorac Cardiovasc Surg       Date:  2001-02       Impact factor: 5.209

7.  Improved right ventricular function following late pulmonary valve replacement for residual pulmonary insufficiency or stenosis.

Authors:  E L Bove; R E Kavey; C J Byrum; H M Sondheimer; M S Blackman; F D Thomas
Journal:  J Thorac Cardiovasc Surg       Date:  1985-07       Impact factor: 5.209

8.  Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of fallot.

Authors:  Hubert W Vliegen; Alexander van Straten; Albert de Roos; Arno A W Roest; Paul H Schoof; Aeilko H Zwinderman; Jaap Ottenkamp; Ernst E van der Wall; Mark G Hazekamp
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

9.  Surgical management of chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction.

Authors:  Cheul Lee
Journal:  Korean Circ J       Date:  2012-01-31       Impact factor: 3.243

10.  Effect of ventricular size and function on exercise performance and the electrocardiogram in repaired tetralogy of Fallot with pure pulmonary regurgitation.

Authors:  Shaji C Menon; Aditya K Kaza; Michael D Puchalski
Journal:  Ann Pediatr Cardiol       Date:  2012-07
  10 in total
  5 in total

Review 1.  Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.

Authors:  Mouhammad Fathallah; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2017-09-16       Impact factor: 2.931

Review 2.  Pulmonary Valve Regurgitation: Neither Interventional Nor Surgery Fits All.

Authors:  Antonio F Corno
Journal:  Front Pediatr       Date:  2018-06-07       Impact factor: 3.418

3.  Trifecta St. Jude medical® aortic valve in pulmonary position.

Authors:  Antonio F Corno; Alan G Dawson; Aidan P Bolger; Branco Mimic; Suhair O Shebani; Gregory J Skinner; Simone Speggiorin
Journal:  Nano Rev Exp       Date:  2017-05-01

4.  Whether Pulmonary Valve Replacement in Asymptomatic Patients With Moderate or Severe Regurgitation After Tetralogy of Fallot Repair Is Appropriate: A Case-Control Study.

Authors:  Fengpu He; Zicong Feng; Qiuming Chen; Yiping Jiao; Zhongdong Hua; Hao Zhang; Keming Yang; Kunjing Pang; Minjie Lu; Kai Ma; Sen Zhang; Lei Qi; Guanxi Wang; Shoujun Li
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

5.  The role of preoperative sildenafil therapy in controlling of postoperative pulmonary hypertension in children with ventricular septal defects.

Authors:  Hamid Bigdelian; Mohsen Sedighi
Journal:  J Cardiovasc Thorac Res       Date:  2017-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.